Lomexin Vaginal
1-[2-(2,4-Dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 51755.
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Acino Pharma (Pty) Ltd | Lomexin vaginal | cream | 290055 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Lomexin vaginal cream EACH 5 g CREAM CONTAINS FENTICONAZOLE NITRATE 100 mg | Cream | 29005529/18.6/0055 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Fenticonazole
Consolidated Schedules 06 July 2026, line 6326
S3: Fenticonazole
- except when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 3585
S1: Fenticonazole
- when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 437
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.